Skip to main content

Day: February 4, 2021

Banco Santander-Chile Announces Fourth Quarter 2020 Earnings

SANTIAGO, Chile, Feb. 04, 2021 (GLOBE NEWSWIRE) — Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its unaudited results1 for the twelve month period ended December 31, 2020 and fourth quarter 2020 (4Q20).Net income attributable to shareholder up 57.2% YoY in 4Q20. ROAE of 20.4% in 4Q20Net income attributable to shareholders in 4Q20 totaled Ch$183,435 million (Ch$0.97 per share and US$0.55 per ADR), increasing 74.5% compared to 3Q20 from now on QoQ) and increasing 57.2% compared to 4Q19. It is important to point out that 4Q20 results include an additional provision of Ch$50,000 million recognized in order to increase coverage ratios considering the uncertainty surrounding the potential impacts on credit quality of the COVID-19 crisis. Even with this impact, net income increased 74.5% QoQ due to higher net interest...

Continue reading

THC Therapeutics Has Joined the Las Vegas Medical Marijuana Association.

The company will utilize the connections of the LVMMA to raise capital, and seek mergers & acquisitions.THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded technology company, whose mission statement is, “Better Health through the Science of Nature,” is pleased to announce today that the company has joined the Las Vegas Medical Marijuana Association (LVMMA).LAS VEGAS, Feb. 04, 2021 (GLOBE NEWSWIRE) — THCT plans to leverage the diverse membership of dispensary owners, production facilities, cultivators, labs and various companies to further the company’s growth strategy.As mentioned in our previous press release, the company is moving forward with its financing plans by potentially raising up to $75 million via a Reg A+ offering. Investors that are interested in more information regarding the planned...

Continue reading

Autolus Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 4

LONDON, Feb. 04, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its fourth quarter and full year 2020 financial results and operational highlights before open of U.S. markets on Thursday, March 4, 2021.Management will host a conference call and webcast at 8:30 am ET/1:30 pm GMT to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ websiteThe call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 2268057. After the conference call, a replay...

Continue reading

Axogen, Inc. to Participate at Upcoming February Investor Conferences

ALACHUA, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced it will participate in two investor conferences in February.Karen Zaderej, chairman, CEO, and president, will participate in a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18, 2021 at 9:00 a.m. ET.Ms. Zaderej will also participate in a fireside discussion at the 10th Annual SVB Leerink Global Healthcare Conference to be held virtually this year. The discussion is scheduled for Wednesday, February 24, 2021 at 2:20 p.m. ET.Both discussions will be webcast live and can be accessed through the Investors page at www.axogeninc.com. For those...

Continue reading

REMINDER – Saputo Inc.: Fiscal 2021 Third Quarter Results

MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – A conference call for analysts and institutional investors will be held on Thursday, February 4, 2021, at 2:30 p.m. (Eastern Time), to discuss the fiscal 2021 third quarter results.The conference call will begin with a short presentation followed by a question and answer period. The speakers will be Mr. Lino A. Saputo, Chair of the Board and Chief Executive Officer, Mr. Maxime Therrien, Chief Financial Officer and Secretary, and Mr. Kai Bockmann, President and Chief Operating Officer, Saputo Inc. and International Sector.To participate in the conference: 1-800-941-4658Please dial-in approximately five minutes before the call.To listen to the call on the Web: http://www.gowebcasting.com/11052.Replay of the conferenceA replay of the conference call will be available...

Continue reading

RAPPEL – Saputo inc. : Résultats du troisième trimestre de l’exercice 2021

MONTRÉAL, 04 févr. 2021 (GLOBE NEWSWIRE) — Saputo inc. (TSX:SAP) – Une conférence téléphonique pour les analystes et les investisseurs institutionnels, traitant des résultats du troisième trimestre de l’exercice 2021, aura lieu le jeudi 4 février 2021, à 14 h 30 (heure de l’Est).La conférence débutera par une courte présentation, suivie d’une période de questions. Les conférenciers seront M. Lino A. Saputo, président du conseil d’administration et chef de la direction, M. Maxime Therrien, chef de la direction financière et secrétaire ainsi que M. Kai Bockmann, président et chef de l’exploitation, Saputo inc. et Secteur InternationalPour participer à la conférence : 1-800-941-4658Veuillez SVP signaler ce numéro cinq minutes avant le début de la conférence.Pour écouter cet appel sur le Web : http://www.gowebcasting.com/11053.Enregistrement...

Continue reading

REMINDER – Saputo Inc.: Fiscal 2021 Third Quarter Results

MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – A conference call for analysts and institutional investors will be held on Thursday, February 4, 2021, at 2:30 p.m. (Eastern Time), to discuss the fiscal 2021 third quarter results.The conference call will begin with a short presentation followed by a question and answer period. The speakers will be Mr. Lino A. Saputo, Chair of the Board and Chief Executive Officer, Mr. Maxime Therrien, Chief Financial Officer and Secretary, and Mr. Kai Bockmann, President and Chief Operating Officer, Saputo Inc. and International Sector.To participate in the conference: 1-800-941-4658Please dial-in approximately five minutes before the call.To listen to the call on the Web: http://www.gowebcasting.com/11052.Replay of the conferenceA replay of the conference call will be available...

Continue reading

Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study

SAN DIEGO, Feb. 04, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that CRN04894, the company’s lead adrenocorticotropic hormone (ACTH) antagonist for the treatment of diseases associated with excess ACTH such as Cushing’s disease and congenital adrenal hyperplasia (CAH), has advanced into the clinic. Based on encouraging preclinical results, Crinetics has initiated a double-blind, randomized, placebo-controlled Phase 1 study of this orally administered, nonpeptide small molecule drug candidate in healthy volunteers. This study will assess the safety and tolerability of single and multiple doses of CRN04894 and...

Continue reading

VSBLTY PARTNERS WITH 911INFORM TO IMPROVE EMERGENCY RESPONSE, SAFETY & SECURITY IN SCHOOLS, HOSPITALS & OFFICES

Philadelphia, PA, Feb. 04, 2021 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and retail marketing technology, is partnering with 911inform to provide tighter safety and security measures for schools, universities and campus environments. 911inform is an emergency management solution that provides first responders and on-site personnel with real-time situational awareness and pinpoint location data during an emergency. 911inform provides detailed maps and visuals of the affected area and gives authorities bidirectional communication and control of doors, cameras, phones, HVAC, fire and alarm systems, intercom, strobes and other IOT premised-based technologies.What is unique about the 911inform-VSBLTY solution is that the combined technology provides...

Continue reading

CORPAC Awards Gilat Multi-Million-Dollar Contract to Provide Mission Critical Telecom Systems for Peru’s Airports

PETAH TIKVA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that it was awarded a multi-million-dollar contract to provide mission critical telecom systems for 29 of Peru’s airports. The award of high-availability communication system was granted by CORPAC, the Peruvian Corporation of Commercial Airports and Aviation. This award follows Gilat’s successful execution of large government projects and well positions Gilat for additional large deals in Peru.CORPAC is a government entity in charge of the administration of most of the airports in Peru. Gilat will design, supply, implement and commission equipment for Communication Navigation and Surveillance (CNS) services in Peru’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.